Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 1 · 33.3%Very low 0 · 0%Low 0 · 0%Moderate 2 · 66.7%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Related · question page
- Azithromycin vs placebo or vitamins · Minor participant‐reported adverse events not requiring withdrawal of the treatment: Mild abdominal pain.
  Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
  RR 5.82 [0.72, 47.1]
  2 studies · 119 participants
  Moderate
Related · question page
- Azithromycin vs placebo or vitamins · Serious adverse events, i.e. serious enough to require withdrawal of the treatment
  Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 119 participants
  Moderate
Related · question page
- Azithromycin vs vitamin C · Proportion of participants with adverse events and severe adverse events
  Antistreptococcal interventions for guttate and chronic plaque psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 50 participants
  GRADE not reported

Azithromycin vs vitamin C

Proportion of participants with adverse events and severe adverse events · people with chronic plaque psoriasis

1 finding from 1 review

Antistreptococcal interventions for guttate and chronic plaque psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
GRADE not reported

Azithromycin vs placebo or vitamins

Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 119 participants
Moderate

Azithromycin vs placebo or vitamins

Minor participant‐reported adverse events not requiring withdrawal of the treatment: Mild abdominal pain. · pityriasis rosea

Azithromycin showed no clear difference in minor participant‐reported adverse events not requiring withdrawal… compared with placebo or vitamins (moderate certainty).

1 finding from 1 review

Interventions for pityriasis rosea 2019 · Cochrane Headline outcomes only
RR 5.82 [0.72, 47.1]
2 studies · 119 participants
Moderate